Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
518 trades
$10.3T in total
Open-market sales
1,242 trades
$1.4B in total
Insiders filing
580 insiders
Last 7 days
Trade type
10% Owner
Grace TherapeuticsGRCE
Open-market buyAmendment09/21–09/2910/0122,938 sh3 trades$2.10avg.$48,091.31+0.8%